Protein Oxidative Stress and Dyslipidemia in Dialysis Patients


Autoria(s): de Mattos, Andresa Marques; Marino, Larissa Vieira; Ovidio, Paula Payao; Jordao, Alceu Afonso; Almeida, Carla Cristina; Chiarello, Paula Garcia
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

05/11/2013

05/11/2013

2012

Resumo

Our aim was to investigate and determine the associations between oxidative stress (OS), dyslipidemia and inflammation in patients treated with continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis (HD) using observational cross-sectional study. Twenty patients in CAPD and 48 in HD for at least 8 weeks and aged =18 years were included in the study. Individuals with malignant or acute inflammatory disease were excluded. A control group of 17 healthy individuals was also recruited. The biochemical parameter evaluations were analyzed using colorimetric kits for albumin, serum glucose, total cholesterol (TC) and lipid fractions. To determine the inflammatory status, CRP, IL-6 and TNF-a were analyzed by automated chemiluminescence kits. Plasma advanced oxidation protein products (AOPP) were determined by spectrophotometry. Mean AOPP levels were significantly higher for the HD group compared to the control, and there was no difference in AOPP concentrations between the control and CAPD groups. Dialysis patients had levels of inflammatory parameters higher than controls, and showed a high prevalence of patients with dyslipidemia, especially in CAPD. In the HD group, AOPP was positively correlated with triglycerides (TG) and inversely associated with HDL. Also the HD group was observed to have negative associations between TNF-a and HDL, LDL and TC. In the CAPD group, CRP was inversely correlated with HDL. Hemodialysis patients had increased protein OS and associations of inflammation and dyslipidemia were also observed in these dialysis groups. A more detailed characterization of the relations between oxidative stress and other more traditional risk factors has therapeutic importance, since cardiovascular diseases are the leading cause of death among dialysis patients.

Identificador

THERAPEUTIC APHERESIS AND DIALYSIS, MALDEN, v. 16, n. 1, supl., Part 3, pp. 68-74, FEB, 2012

1744-9979

http://www.producao.usp.br/handle/BDPI/41699

10.1111/j.1744-9987.2011.01009.x

http://dx.doi.org/10.1111/j.1744-9987.2011.01009.x

Idioma(s)

eng

Publicador

WILEY-BLACKWELL

MALDEN

Relação

THERAPEUTIC APHERESIS AND DIALYSIS

Direitos

closedAccess

Copyright WILEY-BLACKWELL

Palavras-Chave #ADVANCED OXIDATION PRODUCTS #DIALYSIS #DYSLIPIDEMIA #INFLAMMATION #PROTEIN OXIDATIVE STRESS #PERITONEAL-DIALYSIS #HEMODIALYSIS-PATIENTS #LIPID PROFILE #INFLAMMATION #PRODUCTS #PLASMA #DISEASE #CHOLESTEROL #FAILURE #MARKERS #HEMATOLOGY #UROLOGY & NEPHROLOGY
Tipo

article

original article

publishedVersion